Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hester Biosciences Ltd Board/Management Information 2022

Apr 7, 2022

62222_rns_2022-04-07_8137affc-68b5-48a2-b9e3-c128a78a2bcf.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [596 x 128] intentionally omitted <==

7 April 2022

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai 400 051

Scrip Code: 524669

Symbol: HESTERBIO

Dear Sir / Madam:

Subject: Outcome of Board Meeting

Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the execution of Grantin-Aid Letter Agreement for grant of INR 600 million (in phased manner) to the Company by Biotechnology Industry Research Assistance Council (BIRAC), a Government of India Enterprise to support COVID vaccine manufacturing under Mission Covid Suraksha.

The Board Meeting commenced at 3:00 p.m. (IST) and concluded at 3:22 p.m. (IST)

You are requested to take the above information on your record.

Sincerely For Hester Biosciences Limited

==> picture [76 x 37] intentionally omitted <==

Vinod Mali Company Secretary & Compliance Officer